Cargando…
Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
The aim of this case report is to describe a case of atypical central serous chorioretinopathy (CSCR) definitively diagnosed after 8 years. A 44-year-old woman presented with reduced visual acuity in her left eye. Her visual acuity was light perception with projection in the right eye and 0.15 in th...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069095/ https://www.ncbi.nlm.nih.gov/pubmed/35481737 http://dx.doi.org/10.4274/tjo.galenos.2022.93213 |
_version_ | 1784700354833678336 |
---|---|
author | Yanık, Özge Batıoğlu, Figen Yalçındağ, Nilüfer Demirel, Sibel Özmert, Emin |
author_facet | Yanık, Özge Batıoğlu, Figen Yalçındağ, Nilüfer Demirel, Sibel Özmert, Emin |
author_sort | Yanık, Özge |
collection | PubMed |
description | The aim of this case report is to describe a case of atypical central serous chorioretinopathy (CSCR) definitively diagnosed after 8 years. A 44-year-old woman presented with reduced visual acuity in her left eye. Her visual acuity was light perception with projection in the right eye and 0.15 in the left. She described a similar decline in vision in her right eye 8 years ago. At that time, she had exudative retinal detachment and was treated with systemic immunosuppressive therapy for a presumed diagnosis of Vogt-Koyanagi-Harada disease. Despite resolution of the exudative retinal detachment, macular scarring developed. Eight years later, she developed inferior exudative retinal detachment in the left eye. A diagnosis of atypical CSCR was made with the help of multimodal imaging and her left eye was successfully treated with eplerenone and half-fluence photodynamic therapy (hf-PDT). In conclusion, early diagnosis and treatment of atypical CSCR may prevent subretinal fibrosis formation and permanent vision loss. Hf-PDT and eplerenone are successful treatment options for atypical CSCR. |
format | Online Article Text |
id | pubmed-9069095 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-90690952022-05-13 Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy Yanık, Özge Batıoğlu, Figen Yalçındağ, Nilüfer Demirel, Sibel Özmert, Emin Turk J Ophthalmol Case Report The aim of this case report is to describe a case of atypical central serous chorioretinopathy (CSCR) definitively diagnosed after 8 years. A 44-year-old woman presented with reduced visual acuity in her left eye. Her visual acuity was light perception with projection in the right eye and 0.15 in the left. She described a similar decline in vision in her right eye 8 years ago. At that time, she had exudative retinal detachment and was treated with systemic immunosuppressive therapy for a presumed diagnosis of Vogt-Koyanagi-Harada disease. Despite resolution of the exudative retinal detachment, macular scarring developed. Eight years later, she developed inferior exudative retinal detachment in the left eye. A diagnosis of atypical CSCR was made with the help of multimodal imaging and her left eye was successfully treated with eplerenone and half-fluence photodynamic therapy (hf-PDT). In conclusion, early diagnosis and treatment of atypical CSCR may prevent subretinal fibrosis formation and permanent vision loss. Hf-PDT and eplerenone are successful treatment options for atypical CSCR. Galenos Publishing 2022-04 2022-04-28 /pmc/articles/PMC9069095/ /pubmed/35481737 http://dx.doi.org/10.4274/tjo.galenos.2022.93213 Text en © Copyright 2022 by Turkish Ophthalmological Association | Turkish Journal of Ophthalmology, published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Yanık, Özge Batıoğlu, Figen Yalçındağ, Nilüfer Demirel, Sibel Özmert, Emin Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy |
title | Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy |
title_full | Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy |
title_fullStr | Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy |
title_full_unstemmed | Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy |
title_short | Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy |
title_sort | atypical chronic central serous chorioretinopathy mimicking vogt-koyanagi-harada disease: full therapeutic response to half-fluence photodynamic therapy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069095/ https://www.ncbi.nlm.nih.gov/pubmed/35481737 http://dx.doi.org/10.4274/tjo.galenos.2022.93213 |
work_keys_str_mv | AT yanıkozge atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy AT batıoglufigen atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy AT yalcındagnilufer atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy AT demirelsibel atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy AT ozmertemin atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy |